- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT02436616
microEEG for Neonatal Apnea, Bradycardia and Desaturation
Wireless Novel microEEG for Neonatal Apnea and Community Neurological Network
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Most preterm infants have episodes of apnea (cessation of breathing), bradycardia (low heart rate), and desaturations (low levels of oxygen in the blood) (ABD events). The resolution of ABD episodes depends to a large extent on the maturation of the central nervous system (CNS). The electroencephalogram (EEG) is a reliable and noninvasive tool for recording the electrical activity of the CNS. The relationship between ABD events and cerebral electrical activity has not been well investigated. The investigators seek to examine the relationship between EEG findings and the resolution of ABD events in the developing premature infant.
To investigate this relationship and obtain findings which are relevant to clinical care, a variety of obstacles need to be overcome. Among these obstacles is the high cost of standard EEG machines, inability of most standard machines to operate in electrically-noisy environments such as the NICU, and the absence of full-time coverage neurologists for prompt EEG interpretation. The investigators seek to determine the feasibility of obtaining an artifact-free EEG in the NICU with accurate detection of background rhythm abnormalities. The investigators will utilize an existing digital wireless telemetry unit, the "microEEG" for the NICU for this purpose. The microEEG device is specifically designed to overcome obstacles to standard EEG recording.
To address the shortage of trained pediatric neurophysiologists, the investigators will investigate the feasibility of a case management system for centralized EEG interpretation using off-site neurologists.
Finally, the investigators will examine the inter-rater reliability of EEG interpretation in the developing premature infant. This will allow the development of consensus guidelines for EEG interpretations.
Type d'étude
Inscription (Anticipé)
Contacts et emplacements
Lieux d'étude
-
-
New York
-
Brooklyn, New York, États-Unis, 11203
- Recrutement
- State University of New York/Downstate Medical Center
-
Contact:
- Zachary Ibrahim, MD
- Numéro de téléphone: 718-613-8442
- E-mail: zachary.Ibrahim@downstate.edu
-
Contact:
- Geetha Chari, MD
- Numéro de téléphone: 9177600714
- E-mail: geetha.chari@downstate.edu
-
Brooklyn, New York, États-Unis, 11212
- Recrutement
- Brookdale University Hospital and Medical Center,
-
Contact:
- Roger Kim, MD
- Numéro de téléphone: 917-836-3613
- E-mail: rkim@brookdale.edu
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- gestational age (GA) 24-32 weeks
postnatal ages 0-30 days. The patients will be recruited upon manifesting one of the following
- apneas (cessation of breathing > 10 seconds) x2 in a 12 hour span
- bradycardias (HR < 100/min) x2 in 12 hours
- oxygen desaturations (<80%) x 2 in 12 hours
- a single ABD event that does not resolve with stimulation or an increase in fractional oxygen delivery (FiO2).
Exclusion Criteria:
- major malformations
- The infant has exposed dermis on the scalp due to immaturity
Any scalp skin lesions such as pustules, large abrasions The patient will be Withdrawn if
- Informed consent is withdrawn
- adverse events (i.e..scalp lesions) develop
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
|---|---|
|
EEG monitoring
All subjects enrolled in this observational study will undergo EEG monitoring using the microEEG device.
|
microEEG is a miniature, wireless, and battery-powered EEG device used to obtain EEG recording in challenging environment. All infants have an initial EEG at study enrollment. Follow up microEEGs will be performed at approximately 2-4 week intervals, depending on the Corrected Gestational Age (CGA). If ABD events have not resolved at 34 weeks, an 8 hour recording will be performed prior to discharge or at 42 weeks CGA, whichever comes first. EEG will be assessed in 3 hour epochs. The EEG will be reviewed off line by two blinded neurologists and classified as normal or abnormal based on CGA and other findings. Follow up EEGs will be scored similarly, with emphasis on maturation. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Correlation between EEG background activity and resolution of Apnea, Bradycardia and Desaturation
Délai: Initial 8-9 hours EEG will be done upon study enrollment in the first 30 days of life.
|
Primary outcome measure is to assess the background EEG activity in infants with ABD events and determine the relationship between abnormal initial EEG background activity and the resolution of ABD events at 34 weeks Corrected Gestational Age
|
Initial 8-9 hours EEG will be done upon study enrollment in the first 30 days of life.
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Rate of seizure activity.
Délai: From study enrollement to resolution of ABD events or 42 weeks corrected gesational age, whichever, comes first.
|
All EEG recordings will be assessed by a pediatric neurophysiologist for seizure activity using standard clinical criteria.
Based on their findings the rate of seizure will be determined.
|
From study enrollement to resolution of ABD events or 42 weeks corrected gesational age, whichever, comes first.
|
|
Feasibility of microEEG recording in the NICU
Délai: From study enrollment (first 30 days of life) to resolution of ABD events or 42 weeks gesational age (whichever comes first)
|
Assess the ability of neonatal staff to utilize the microEEG to obtain EEG in the NICU.
This will be done by measuring the percentage of completed recordings that are interpretable by a pediatric neurophysiologist.
|
From study enrollment (first 30 days of life) to resolution of ABD events or 42 weeks gesational age (whichever comes first)
|
|
Interrater reliability of neonatal EEG interpretation
Délai: From study enrollment (first 30 days of life) to resolution of ABD events or 42 weeks gesational age (whichever comes first)
|
Assess the inter-rater reliability of neonatal EEG interpretations using data obtained in the course of the study.
|
From study enrollment (first 30 days of life) to resolution of ABD events or 42 weeks gesational age (whichever comes first)
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Zachary Ibrahim, MD, State University of New York - Downstate Medical Center
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Anticipé)
Achèvement de l'étude (Anticipé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
- Processus pathologiques
- Maladies cardiaques
- Maladies cardiovasculaires
- Maladies du système nerveux
- Maladies des voies respiratoires
- Troubles respiratoires
- Manifestations neurologiques
- Signes et symptômes respiratoires
- Arythmies cardiaques
- Complications de grossesse
- Complications du travail obstétrical
- Travail obstétrique, prématuré
- Apnée
- Naissance prématurée
- Bradycardie
- Saisies
Autres numéros d'identification d'étude
- 307016-7
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .